前沿论文｜CELL INTELLIGENCE

Lipid nanoparticle-based multi-scale systemic immune programming for cancer therapy.

PubMed 2026/08/10 发表Mol TherQ1 · IF 11.4（JCR 2025）

A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.

PubMed 2026/07/30 发表J Hematol OncolQ1 · IF 47.8（JCR 2025）

In Vivo mRNA-Lipid Nanoparticle CAR-T Cell Engineering: Advances, Challenges, and Clinical Translation.

PubMed 2026/06/03 发表BiomedicinesQ2 · IF 4.5（JCR 2025）

Reprogramming CD22 CAR-T cells in vivo using CD8-targeted mRNA-LNPs to treat hematological malignancies.

PubMed 2026/02/13 发表Mol TherQ1 · IF 11.4（JCR 2025）

Innovative gene engineering strategies to address tumor antigen escape in cell therapy.

PubMed 2025/11/05 发表J Transl MedQ1 · IF 9.7（JCR 2025）

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors.

PubMed 2025/01/06 发表Front ImmunolQ1 · IF 7（JCR 2025）

Boosting CAR-T cell therapy through vaccine synergy.

PubMed 2025/01/03 发表Trends Pharmacol SciQ1 · IF 24（JCR 2025）

Titrating chimeric antigen receptors on CAR T cells enabled by a microfluidic-based dosage-controlled intracellular mRNA delivery platform.

PubMed 2024/12/18 发表BiomicrofluidicsQ2 · IF 2.7（JCR 2025）

Oxidized mRNA Lipid Nanoparticles for In Situ Chimeric Antigen Receptor Monocyte Engineering.

PubMed 2024/03/05 发表Adv Funct MaterQ1 · IF 19.9（JCR 2025）

前沿论文 9